| Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures Y Şenbabaoğlu, RS Gejman, AG Winer, M Liu, EM Van Allen, ... Genome biology 17, 1-25, 2016 | 774 | 2016 |
| Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology RJ Motzer, E Jonasch, N Agarwal, A Alva, M Baine, K Beckermann, ... Journal of the National Comprehensive Cancer Network 20 (1), 71-90, 2022 | 332 | 2022 |
| Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score A Kutikov, MC Smaldone, BL Egleston, BJ Manley, DJ Canter, J Simhan, ... European urology 60 (2), 241-248, 2011 | 292 | 2011 |
| Utility of the RENAL nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass D Canter, A Kutikov, B Manley, B Egleston, J Simhan, M Smaldone, ... Urology 78 (5), 1089-1094, 2011 | 211 | 2011 |
| NCCN guidelines insights: kidney cancer, version 2.2020: featured updates to the NCCN guidelines RJ Motzer, E Jonasch, MD Michaelson, L Nandagopal, JL Gore, S George, ... Journal of the National Comprehensive Cancer Network 17 (11), 1278-1285, 2019 | 207 | 2019 |
| NCCN guidelines insights: kidney cancer, version 1.2021: featured updates to the NCCN guidelines RJ Motzer, E Jonasch, S Boyle, MI Carlo, B Manley, N Agarwal, A Alva, ... Journal of the National Comprehensive Cancer Network 18 (9), 1160-1170, 2020 | 195 | 2020 |
| Robot-assisted partial nephrectomy: a large single-institutional experience BJ Scoll, RG Uzzo, DYT Chen, SA Boorjian, A Kutikov, BJ Manley, ... Urology 75 (6), 1328-1334, 2010 | 152 | 2010 |
| Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer CC Peyton, D Tang, RR Reich, M Azizi, J Chipollini, JM Pow-Sang, ... JAMA oncology 4 (11), 1535-1542, 2018 | 134 | 2018 |
| Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma J Casuscelli, N Weinhold, G Gundem, L Wang, EC Zabor, E Drill, PI Wang, ... JCI insight 2 (12), 2017 | 113 | 2017 |
| Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: a braided cancer river model of kidney cancer JJ Hsieh, BJ Manley, N Khan, JJ Gao, MI Carlo, EH Cheng Seminars in cell & developmental biology 64, 98-106, 2017 | 57 | 2017 |
| Characterization and impact of TERT promoter region mutations on clinical outcome in renal cell carcinoma J Casuscelli, MF Becerra, BJ Manley, EC Zabor, E Reznik, ... European urology focus 5 (4), 642-649, 2019 | 48 | 2019 |
| Chromophobe renal cell carcinoma: results from a large single-institution series J Casuscelli, MF Becerra, K Seier, BJ Manley, N Benfante, ... Clinical genitourinary cancer 17 (5), 373-379. e4, 2019 | 47 | 2019 |
| Integration of recurrent somatic mutations with clinical outcomes: a pooled analysis of 1049 patients with clear cell renal cell carcinoma BJ Manley, EC Zabor, J Casuscelli, DM Tennenbaum, A Redzematovic, ... European urology focus 3 (4-5), 421-427, 2017 | 45 | 2017 |
| Cystic renal cell carcinoma: a report on outcomes of surgery and active surveillance in patients retrospectively identified on pretreatment imaging M Kashan, M Ghanaat, AM Hötker, C Duzgol, A Sanchez, RG DiNatale, ... The Journal of urology 200 (2), 275-282, 2018 | 40 | 2018 |
| Tumor xenografts of human clear cell renal cell carcinoma but not corresponding cell lines recapitulate clinical response to sunitinib: feasibility of using biopsy samples Y Dong, BJ Manley, MF Becerra, A Redzematovic, J Casuscelli, ... European urology focus 3 (6), 590-598, 2017 | 37 | 2017 |
| Genomic alterations and outcomes with VEGF-targeted therapy in patients with clear cell renal cell carcinoma MI Carlo, B Manley, S Patil, KM Woo, DT Coskey, A Redzematovic, ... Kidney Cancer 1 (1), 49-56, 2017 | 37 | 2017 |
| Comparative genomic profiling of matched primary and metastatic tumors in renal cell carcinoma MF Becerra, E Reznik, A Redzematovic, DM Tennenbaum, M Kashan, ... European urology focus 4 (6), 986-994, 2018 | 35 | 2018 |
| Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations BJ Manley, E Reznik, M Ghanaat, M Kashan, MF Becerra, J Casuscelli, ... Urologic Oncology: Seminars and Original Investigations 37 (1), 12-17, 2019 | 32 | 2019 |
| Pathological and survival outcomes associated with variant histology bladder cancers managed by cystectomy with or without neoadjuvant chemotherapy A Hajiran, M Azizi, AM Aydin, L Zemp, CC Peyton, J Dhillon, S Nealon, ... The Journal of urology 205 (1), 100-108, 2021 | 29 | 2021 |
| The difficulty in selecting patients for cytoreductive nephrectomy: an evaluation of previously described predictive models BJ Manley, DM Tennenbaum, EA Vertosick, JJ Hsieh, DD Sjoberg, ... Urologic Oncology: Seminars and Original Investigations 35 (1), 35. e1-35. e5, 2017 | 28 | 2017 |
